|
|
|
Insider
Information: |
Riedel Norbert G |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
854,950 |
|
Indirect Shares
|
740,608 |
|
|
Direct
Value |
$5,828,888 |
|
|
Indirect Value
|
$71,098 |
|
|
Total
Shares |
1,595,558 |
|
|
Total
Value |
$5,899,986 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-38.2%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Baxter International Inc |
BAX |
Corporate Vice President |
2013-01-16 |
56,689 |
2005-03-14 |
0 |
Premium* |
|
Oscient Pharmaceuticals Corp |
OSCIQ |
Director |
2008-06-12 |
1,340 |
2006-06-08 |
0 |
Premium* |
|
Ariad Pharmaceuticals Inc |
ARIA |
Director |
2016-02-01 |
121,859 |
2011-04-28 |
0 |
Premium* |
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-08-14 |
13,705 |
2013-05-09 |
0 |
Premium* |
|
Aptinyx Inc. |
APTX |
|
2021-12-06 |
615,265 |
2021-12-06 |
740,608 |
Premium* |
|
Cerevel Therapeutics Holdings, I... |
CERE |
Director |
2023-06-07 |
46,092 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
75 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BAX |
Baxter International Inc |
Corporate Vice President |
|
2005-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
27,247 |
|
- |
|
BAX |
Baxter International Inc |
Corporate Vice President |
|
2006-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,200 |
37,994 |
|
- |
|
OSCIQ |
Oscient Pharmaceuticals C... |
Director |
|
2006-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,400 |
5,919 |
|
- |
|
BAX |
Baxter International Inc |
Corporate Vice President |
|
2007-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,800 |
40,418 |
0 |
- |
|
OSCIQ |
Oscient Pharmaceuticals C... |
Director |
|
2007-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
300 |
1,040 |
0 |
- |
|
OSCIQ |
Oscient Pharmaceuticals C... |
Director |
|
2008-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
300 |
1,340 |
0 |
- |
|
BAX |
Baxter International Inc |
Corporate Vice President |
|
2010-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
56,424 |
0 |
- |
|
BAX |
Baxter International Inc |
Corporate Vice President |
|
2011-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,302 |
53,066 |
0 |
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2011-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
52,000 |
0 |
- |
|
BAX |
Baxter International Inc |
Corporate Vice President |
|
2013-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
5,799 |
58,614 |
0 |
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2013-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
84,359 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2013-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,000 |
0 |
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2014-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
96,859 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2014-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,650 |
5,006 |
0 |
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2015-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
109,359 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2015-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,310 |
5,666 |
0 |
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2016-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
121,859 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2016-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,365 |
5,586 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2017-08-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,365 |
6,318 |
0 |
- |
|
APTX |
Aptinyx Inc. |
CEO and President |
|
2018-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
116,481 |
323,976 |
0 |
- |
|
APTX |
Aptinyx Inc. |
CEO and President |
|
2018-06-25 |
4 |
A |
$0.00 |
$0 |
I/I |
2,718 |
2,718 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2018-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,495 |
7,151 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2019-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,920 |
8,411 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2020-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,705 |
10,390 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2021-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,246 |
11,705 |
0 |
- |
|
75 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|